Jay Gunawardana - Publications

Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.

Journal: American journal of hematology

Published: June 10, 2024

Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.

Journal: EBioMedicine

Published: March 24, 2024

The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma.

Journal: Acta haematologica

Published: May 17, 2023

A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra-high-risk patient with diffuse large B-cell lymphoma.

Journal: Internal medicine journal

Published: January 26, 2023

Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy.

Journal: Clinical & translational immunology

Published: May 28, 2021

Successful treatment of Epstein-Barr virus-associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third-party Epstein-Barr virus-specific T cells.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 27, 2021

Genetic aberrations of NLRC5 are associated with downregulated MHC-I antigen presentation and impaired T-cell immunity in follicular lymphoma.

Journal: EJHaem

Published: August 25, 2020

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

Journal: Blood

Published: August 05, 2020

Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.

Journal: Blood advances

Published: April 03, 2020

Reply to M. Sorigue.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 10, 2019

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 29, 2019

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.

Journal: Cell reports

Published: July 29, 2019